News
1h
Stocktwits on MSNHims & Hers Stock Slides Pre-Market As Q2 Sales View Misses Estimates, But Retail Traders Shrug It OffTelehealth firm Hims & Hers Health Inc. (HIMS) reported strong first-quarter 2025 results, with revenue more than doubling ...
The global race for weight loss solutions has firmly arrived in India—bringing with it hope, hype, and a host of unanswered ...
The reserarchers found that a weekly dose of semaglutide was effective at treating Metabolic Dysfunction-Associated ...
The Ohio Board of Pharmacy recently revoked the licenses of four Ohio medical spas, with concerns over the sourcing and ...
Explore Hims & Hers' impressive Q1 2025 growth with 111% revenue increase, strategic partnerships, and innovative healthcare solutions.
A major international study has found that semaglutide, a drug already used to treat type 2 diabetes and obesity, can ...
Hims & Hers Health reports strong Q1 results with 111% revenue growth, 38% subscriber growth, and sets 2030 targets. Read ...
That controversial Super Bowl ad appears to have paid off for Hims & Hers as the company's first-quarter revenue doubled year ...
Mass Gen's Dr. Ali Raja explains why some were sent to the emergency room after using semaglutide injections. Raja says some of the symptoms people experienced won't require an ER visit. Raja says not ...
There's a new side effect to Ozempic that is causing users to develop "Ozempic Mouth." Learn why semaglutide medications cause this and what you can to do counteract it. Don't let your weight loss ...
We want you to take advantage of everything Clinical Advisor has to offer. To view unlimited content, log in or register for free.
Robbie Lyle, host of Arsenal Fan TV, reveals his astonishing weight loss journey, shedding 7 inches off his waist by using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results